Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Samsung Biologics (207940 KS)
Watchlist
331
Analysis
Health Care
•
South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Asymchem Laboratories Tianjin
•
27 Jul 2021 10:03
Asymchem Labs A/H Listing Early Look - Fast Growing, Relatively Insulated
Asymchem Laboratories (002821 CH) (AL) aims to raise around US$1-1.5bn in its H-share listing in Hong Kong. The A-shares listed were listed in...
Sumeet Singh
Follow
218 Views
Share
bearish
•
Quantitative Analysis
•
24 Jul 2021 08:22
Asia Shorts: Tencent, CMB, Ping An, Weimob, WuXi, Shimano, Cocokara, HMM, Kakao, Doosan, Yang Ming
The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...
Brian Freitas
Follow
254 Views
Share
bullish
•
Wuxi Biologics
•
20 Jul 2021 18:54
Wuxi Biologics Placement - Similar Deal Will Yield Similar Results
Wuxi Biologics Holdings is looking to raise up to US$1.3bn by selling about 1.8% of Wuxi Biologics (2269 HK). This is the company's 15th placement...
Sumeet Singh
Follow
359 Views
Share
bearish
•
Samsung C&T
•
11 Jul 2021 16:20
KODEX Samsung Group ETF & Samsung C&T Stub's Harsh Discount
If we look at the trend of the price ratio of C&T versus Synthetic over the past two months, we can find something quite interesting in connection...
Sanghyun Park
Follow
232 Views
Share
bullish
•
Samsung Electronics
•
21 Jun 2021 09:53
•
Syndicated
Samsung Is In A Crucial Transition
Samsung is a unique company: one of the best brand names to ever come out of East Asia, covering Samsung's history, where it is today and its future
Asian Century Stocks
Follow
215 Views
Share
First
Previous
25
26
27
28
29
30
31
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x